Association of Red Blood Cell Transfusion, Anemia, and Necrotizing Enterocolitis
NCT04921696 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2023-05-01
Summary
Necrotizing enterocolitis (NEC) is a leading cause of mortality among preterm infants.The pathogenesis of NEC remains unclear with conflicting data regarding the role of red blood cell (RBC) transfusion and anemia. A meta-analysis of retrospective studies demonstrated an association between exposure to RBC transfusion and NEC(adjusted odds ratio, 2.0 \[95% confidence interval, 1.6-2.5\]). However, recent observational studies have found no association between RBC transfusion and NEC or have found RBC transfusion to be protective.
Conditions
- Necrotizing Enterocolitis
- Anemia
- Red Blood Cell (RBC) Transfusion
Interventions
- OTHER
-
RBC transfusion
RBC was transfused to the infants.
- OTHER
-
no-RBC transfusion
RBC was not transfused to the infants.
Sponsors & Collaborators
-
Children's Hospital of Chongqing Medical University
collaborator OTHER -
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
lead OTHER
Eligibility
- Min Age
- 1 Minute
- Max Age
- 28 Days
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-07-01
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- China
Study Locations
More Related Trials
-
Impact of Enteral Feeding on Splanchnic Oxygenation During Packed Red Blood Cell Transfusion in Preterm Infants
NCT06632314 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Neuroprotective Effect of Autologous Cord Blood Combined With Therapeutic Hypothermia Following Neonatal Encephalopathy
NCT02551003 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Inflammation and Cerebral Oxygenation in Preterm Newborns Following Fetal Red Blood Cell Transfusion Compared to Adult Red Blood Cell Transfusion
NCT06851390 ·Status: COMPLETED
-
Survey on the Clinical Use of Recombinant Human Erythropoietin in VLBW and ELBW Infants
NCT05372211 ·Status: UNKNOWN
-
Infant Brain Study Follow-Up at 3 and 4 Years of Age
NCT02619006 ·Status: TERMINATED
-
Autologous Cord Blood Infusion for the Prevention and Treatment of Prematurity Complications In Preterm Neonates
NCT02050971 ·Status: UNKNOWN ·Phase: PHASE1
-
Red Blood Cells From Umbilical Cord for Transfusion of Preterm Infants
NCT05612919 ·Status: COMPLETED ·Phase: NA
-
Transfusion of Prematures Trial
NCT01702805 ·Status: COMPLETED ·Phase: NA
-
Feasibility and Safety of Umbilical Cord Blood Transfusion in the Treatment of Neonatal Cerebral Ischemia and Anemia
NCT03352310 ·Status: UNKNOWN ·Phase: PHASE1
-
Blood Transfusions in Preterm Infants
NCT05331235 ·Status: UNKNOWN
-
Analyses of Anemia in Very Low Birth Weight (VLBW) Infants.
NCT05949788 ·Status: COMPLETED
-
Effect of Erythropoietin in Premature Infants on White Matter Lesions and Neurodevelopmental Outcome
NCT03110341 ·Status: UNKNOWN ·Phase: PHASE3
-
Near-Infrared Spectroscopy and Cranial Doppler in Premature Newborns With Anemia
NCT04509375 ·Status: UNKNOWN
-
Modified Diagnosis and Treatment of Neonatal Hemolysis With ETCOc in sNH
NCT06832800 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Erythropoietin in Premature Infants to Prevent Encephalopathy
NCT02550054 ·Status: TERMINATED ·Phase: PHASE2
-
Clinical Characterization of Very and Extremely Preterm Infants Who Received Excess Erythrocyte Transfusions With Respect to HAS 2014 Recommendations
NCT06909487 ·Status: COMPLETED
-
Erythropoetin Neuroprotection for Neonatal Cardiac Surgery
NCT00513240 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
umBilical Or Adult Donor Red Blood Cells in Extremely Low Gestational Age Neonates and Retinopathy of Prematurity (BORN)
NCT05100212 ·Status: COMPLETED ·Phase: PHASE2
-
Whole-Body Hypothermia for Neonates With Hypoxic-Ischemic Encephalopathy(HIE)
NCT05581927 ·Status: WITHDRAWN ·Phase: NA
-
Application of Transcriptome Sequencing Combined With Family-Based Whole Genome Sequencing in Improving Precise Diagnosis of Critically Ill Newborns in Northeast China
NCT06990334 ·Status: NOT_YET_RECRUITING
-
Bilirubin Neurotoxicity (BN) and Neurodevelopmental Impairment (NDI) in Extremely Preterm (EP) Infants: Avoidable by Reducing the Usual Intravenous Lipid (UL) Administration
NCT04584983 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Cerebral Haemodynamic Changes by Red Blood Cell Transfusion in Neonates
NCT03983694 ·Status: COMPLETED
-
Recombinant Erythropoietin for Neuroprotection in Very Preterm Infants
NCT00910234 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Effect of Erythropoietin on Neurodevelopmental Outcomes in Very Preterm Infants With Intraventricular Hemorrhage
NCT03914690 ·Status: COMPLETED ·Phase: PHASE2
-
Cytokines Associated With Cord Blood Cell Therapy for Neonatal Encephalopathy
NCT02455830 ·Status: UNKNOWN